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Abstract: High dietary intakes of some protein sources, including soy protein, can  
increase colonic DNA damage in animals, whereas some carbohydrates attenuate this. We 
investigated whether inulin and xylo-oligosaccharides (XOS) could be protective against 
DNA strand breaks by adding them to a human colonic simulator consisting of a proximal 
vessel (PV) (pH 5.5) and a distal vessel (DV) (pH 6.8) inoculated with human faeces and 
media containing soy protein. Genotoxicity of the liquid phase and microbial population 
changes in the vessels were measured. Soy protein (3%) was fermented with 1% low 
amylose cornstarch for 10 day followed by soy protein with 1% XOS or 1% inulin for  
10 day. Inulin did not alter genotoxicity but XOS significantly reduced PV genotoxicity 
and increased DV genotoxicity. Inulin and XOS significantly increased butyrate 
concentration in the DV but not PV. Numbers of the key butyrate-producing bacterium 
Faecalibacterium prausnitzii were significantly increased in the PV and DV by inulin but 
significantly decreased by XOS in both vessels. Other bacteria examined were also 
significantly impacted by the carbohydrate treatments or by the vessel (i.e., pH). There was 
a significant overall inverse correlation between levels of damage induced by the ferments 
and levels of sulphate-reducing bacteria, Bacteroides fragilis, and acetate. In conclusion, 
dietary XOS can potentially modulate the genotoxicity of the colonic environment and 
specific bacterial groups and short chain fatty acids may mediate this. 
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1. Introduction 
Most large epidemiological studies have shown an association between diets high in red and 
processed meat and an increased risk of colorectal cancer (CRC) [1]. Experimental studies involving 
animals indicate that high dietary intakes of these and other sources of protein, including a soy protein 
isolate, can increase the genotoxicity of the colonic luminal environment resulting in increased  
colonic DNA damage, whereas dietary fibre is associated with protection against CRC and forms such 
as resistant starch (RS) and arabinoxylan can help protect against dietary protein-induced colonic  
damage [1–5]. This protection appears partly related to the ability of many fibres to reach the large 
bowel and undergo fermentation, resulting in the production of short chain fatty acids (SCFA) and 
possibly other products which promote colonic tissue integrity. A lowering of levels of genotoxic 
protein fermentation products and the acidification of the colonic environment may also contribute to 
the protection. Faecal bulking and reduced stool transit time also reduce exposure of colorectal tissues 
to potentially toxic colonic agents [6]. 
Prebiotic carbohydrates, which selectively stimulate the growth and activity of beneficial bacteria in 
the intestinal tract [7,8], have the potential to help protect against colorectal disease. The best studied 
of the prebiotics are inulin and fructo-oligosaccharides (FOS), while xylo-oligosaccharides (XOS) are 
considered as promising prebiotic candidates [7,9]. XOS oligomers are composed of xylose units 
linked by β-1.4 linkages [2,10]. Due to their β-configuration the oligomers are not degraded by human 
digestive enzymes and reach the large intestine chemically intact, where they act as a substrate for the 
colonic microbiota [10]. There is some evidence that inulin could be genoprotective [11]. Also, inulin has 
been found to increase the abundance of Faecalibacterium prausnitzii [12], a key butyrate-producing 
bacterium with anti-inflammatory properties [13]. The ability to generate butyrate may be important 
for colonic genoprotection, as the ability of dietary RS to protect against high dietary protein-induced 
colonic DNA damage in rats is strongly correlated with levels of this SCFA [3]. Acetate may also play 
a role, as recent evidence suggests it can protect against the toxicity of pathogenic enteric bacteria [14] 
and has an inverse relationship with DNA damage [3]. However, it is not known if XOS can protect 
against dietary protein-induced colonic DNA damage. 
In the present study, we have used a simulator of the human colon inoculated with human faeces 
and a soy protein isolate (that can induce relatively high colonic DNA damage when consumed by  
rats [4]) to examine whether addition of XOS to the simulator can reduce the genotoxicity of the 
fermentation products and whether these effects differ to those induced by addition of inulin. Although 
many proteins are largely digested before reaching the colon in vivo, the increase in colonic DNA 
damage in response to consumption of soy proteins suggests some may reach the colon and undergo 
fermentation, resulting in the production of genotoxic products. SCFA concentrations and bacterial 
numbers were also measured in the simulators during fermentations to determine whether they are 
associated with changes in genotoxicity. 
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2. Experimental Section 
2.1. Faecal Inoculum 
Stool from five healthy adult volunteers, who had not received antibiotics or experienced episodes 
of diarrhoea for 4 weeks prior to the study, were collected on two separate occasions and kept on ice 
for a maximum of 2 h at 5 °C in airtight plastic bags until use. The five samples were mixed together 
in an anaerobic chamber to eliminate inter-individual variation, and then homogenized and diluted in 
anaerobic PBS (0.1 M, pH 7.2) to produce a 20% (w v−1) faecal slurry. The slurry was prepared just 
prior to inoculation of the fermenter. 
2.2. Fermentation Media 
Fermentations were performed using a basal media prepared according to Bruck et al. [15] with 
minor changes: NaCl (0.05 g L−1, Sigma-Aldrich, Sydney, Australia), K2HPO4 (0.02 g L−1, BDH 
Laboratory Supplies, San Jose, CA, USA), KH2PO (0.02 g L−1, Ajax Finechem, Sydney, Australia), 
MgSO4·7H2O (0.005 g L−1, Sigma-Aldrich, Sydney, Australia), CaCl2·2H2O (0.0034 g L−1, BDH 
Laboratory Supplies, San Jose, CA, USA), NaHCO3 (1 g L−1, Sigma-Aldrich, Sydney, Australia), 
haemin (0.0025 g L−1, Sigma-Aldrich, Sydney, Australia), Cystein HCL (0.25 g L−1, Sigma-Aldrich, 
Sydney, Australia), bile salts (0.25 g L−1, Oxoid, Basingstoke, UK), Tween 80 (1 mL L−1,  
Sigma-Aldrich, Sydney, Australia) and vitamin K1 (5 µL L−1, Sigma-Aldrich, Sydney, Australia). The 
media was prepared in 10× stock solutions with pH adjusted to 7.0, sterilized by autoclaving at 121 °C 
for 20 min and kept at 5 °C. Media, ready for use in the fermenter, was prepared from stocks in a volume 
of 3 L just prior to connecting the media reservoir to the fermenter. The media was supplemented with  
3% (w v−1) soy protein (Morlife Pty. Ltd., Labrador, Australia) previously shown to induce relatively 
high numbers of colonic DNA strand breaks when fed to rats at high levels [4]. Carbohydrate sources 
added to the fermenter, at 1% (w v−1), were a highly digestible low amylose cornstarch (3401C, The 
National Starch and Chemical Company, Sydney, Australia), xylo-oligosacharides (XOS) (DP 2-6; 
kindly provided by Danisco Health and Nutrition, Kantvik, Finland) or inulin (DP 2-60; Orafti ST-Gel, 
Beneo-Orafti, Tienen, Belgium). 
2.3. Human Colonic Simulator 
The fermenter was set up as described by Bruck et al. [15] with minor changes. The fermenter 
consisted of two glass vessels, a proximal vessel (PV) and a distal vessel (DV), with operating 
volumes of 220 mL and 320 mL, respectively. The vessels were connected by tubing and material 
from the PV supplied the DV. Vessel temperatures were kept at 37 °C and pH was automatically 
controlled with 0.1 M NaOH. The pH of the PV was kept at 5.5 and the DV at pH 6.8, both similar to 
their corresponding section of the human colon. Both vessels and the media reservoir were magnetically 
stirred and kept anaerobic by continuous gassing with sterile filtered oxygen-free nitrogen. 
The fermenter was set up on the day prior to inoculation (Day 1). Basal media supplemented with  
3% soy protein and 1% cornstarch was added to each vessel to allow anaerobic conditions to develop 
and the temperature to reach 37 °C. On the following day (Day 0) the faecal slurry was added to the 
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vessels to a final concentration of 2% and the first sample (7 mL) was taken. On Day 1 the media 
reservoir and the pump were connected to the PV with a flow rate of 0.03 L h−1 (total transit time of  
18 h). The PV subsequently supplied the DV. The media reservoir was changed every third day. 
Samples (7 mL) were taken daily in the morning from each vessel and kept at −80 °C until further 
analysis. The media contained low amylose cornstarch as the carbohydrate source for the first 10 days 
(days 1–10) followed by 10 days with XOS or inulin as carbohydrate source (days 11–20). The daily 
samples were used for SCFA measurements to assess the stability of the fermentation system which 
reached a steady state on day 6. Results reported are from days 8–10 (low amylose cornstarch) and 
days 18–20 (XOS or inulin) to ensure the fermentation is stabilised and the comparison between the 
low amylase starch and the prebiotic starch is within the same run. 
2.4. Growth and Maintenance of HT29 Cells 
Human HT29 colonocytes were used for assessment of fermenter genotoxicity. Cells were cultured 
in 75 cm3 tissue culture flasks (Greiner Bio-One, Frickenhausen, Germany) containing 20 mL of 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum, 0.37% 
NaHCO3, 0.60% HEPES (Sigma-Aldrich, Sydney, Australia) and 1% antibiotic/antimycotic at 37 °C 
in an atmosphere of 5% CO2. All chemicals were from Invitrogen unless otherwise stated. pH of the 
media was adjusted to 7.3. Cells were passaged once weekly at ~90% confluence. 
2.5. Faecal Water Genotoxicity Assay 
The liquid phase in the PV and DV fermenter is referred to as faecal water. It was isolated from 
samples collected on Days 8, 9 and 10 (low amylose cornstarch) and Days 18, 19 and 20 (XOS or 
inulin) of fermentations in the PV and DV by centrifugation at 2000× g for 45 min at 4 °C and then 
stored at −80 °C. HT29 cells were treated with a homogeneous sample of faecal water from Days 8–10 
combined or Days 18–20 combined. Media from a flask of ~90% confluent HT29 cells was carefully 
removed. Cells were washed twice in 10 mL pre-warmed (37 °C) PBS and incubated with 1 mL 
Trypsin-EDTA (Invitrogen, Carlsbad, NM, USA) for 5 min at 37 °C, 5% CO2. Cells were 
disaggregated in 10 mL pre-warmed (37 °C) supplemented DMEM, counted and diluted to a 
concentration of ~104 cells mL−1. Cell suspensions (2 mL well−1) were added to 6-well tissue culture 
plates (BD Biosciences, San Jose, CA, USA) and incubated overnight at 37 °C, 5% CO2. 
To test the effects of faecal water on the cultured cells, media was removed from cells growing 
overnight and cells were washed twice in 1 mL PBS. Faecal water was diluted to 20% with PBS and 
then 1 mL of the diluted faecal water was added to each well and cells were incubated for 30 min at  
37 °C, 5% CO2. Previous validation of the model, testing 0.1% to 100% of faecal water, had shown  
20% dilution of faecal water was an optimal concentration (data not shown). Control cells were 
incubated with 1 mL 50 μM H2O2 (positive control) (Sigma-Aldrich, Sydney, Australia) and with  
1 mL PBS (negative control). After 30 min, solutions were removed and cells were washed twice in 1 mL 
PBS. Trypsin-EDTA (100 µL) was added to each well and plates were incubated for 5 min at 37 °C,  
5% CO2. Pre-warmed DMEM supplemented with FBS (2 mL) was added to each well and cells were 
carefully disaggregated. From each well 500 µL aliquots were transferred to microcentrifuge tubes, 
and centrifuged at 4000 rpm for 5 min. Media was discarded and cells were then analysed by the comet 
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assay. Trypan blue was added to 20 µL cell suspensions from each well to determine the viability of 
cells (~95% viability was achieved). 
2.6. Comet Assay 
DNA single-strand breaks (SSB) induced by the faecal water treatments were investigated using the 
single-cell gel electrophoresis assay (comet assay) [16,17]. Cells isolated from the faecal water assay 
were resuspended in 200 µL pre-warmed low melting-point agarose (LMA) (Trevigen, Gaithersburg, 
MD, USA) and 45 µL was pipetted onto the 1st well of two comet assay glass slides (Trevigen, 
Gaithersburg, MD, USA). Another 45 µL LMA was added to the remaining cells, mixed briefly and  
45 µL was pipetted onto the 2nd well of each slide. The cell suspension was spread evenly across the 
surface of the glass slide, covered with a cover slip and kept on ice for 30 min to allow the agarose to 
solidify. The cover slips were removed and the slides were immersed in a cold lysis buffer (Trevigen, 
Gaithersburg, MD, USA) at 4 °C for 1 h. Slides were placed in an electrophoresis tank containing 
alkaline electrophoresis buffer (300 mM NaOH, 1 mM Na2EDTA, pH > 13) kept at 4 °C. Slides were 
submerged in the buffer for 20 min before electrophoresis were conducted at 25 V, 300 mM for 20 min. 
Slides were removed from the alkaline buffer and placed in pH neutralizing buffer (400 mM Tris-HCl, 
pH 7.5) three times (5 min each time), fixed in 96% ethanol for 5 min and left to dry at 37 °C for 5 min. 
Slides were stained with propidium iodide (Sigma-Aldrich, Sydney, Australia) and images were 
captured using an Olympus BX-41 fluorescence microscope and the software Image Pro Plus (Media 
Cybernetics Inc., Rockville, MD, USA). Tail length and comet tail moment (the product of tail length 
and the fraction of DNA in the tail) were calculated for ~50 cells per slide using CometScore™ v1.5 
(TriTek Corp., Sumerduck, VA, USA). Apoptotic cells were excluded from the analysis based on  
their morphology. 
2.7. SCFA Analysis 
Fermentation samples (1 mL) from days 1–20 were diluted 1:3 with a solution of 1.68 mM 
Heptanoic acid (internal standard), pH 7, and left for sedimentation of particulate material. 
Supernatants (150 µL) were distilled by vacuum distillation as described by McOrist, et al. [18]. 
Distillates (60 µL) were analysed for SCFA (acetate, butyrate and propionate) in duplicate using an 
Agilent Technologies 6890N Network Gas Chromatograph System fitted with a Zebron ZB-FFAP 
capillary GC column (Dimension: 30 m × 0.53 mm I.D.) (Phenomenex, Torrance, CA, USA) as 
previously described by McOrist et al. [18]. SCFA results from days 8–10 (low amylose cornstarch) 
and days 18–20 (inulin or XOS) were averaged. 
2.8. DNA Extraction and Quantitative PCR (QPCR) 
DNA was extracted from 0.5 mL of the fermentation samples collected on Days 8–10 (low amylose 
cornstarch) and Days 18–20 (XOS and inulin). Samples were centrifuged at 13,000× g for 5 min and 
pellets were resuspended in 1.2 mL TE Buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8) and transferred 
to 2 mL microcentrifuge tubes containing 0.5 mL zirconia-silica beads (0.1 mm, Biospec Products) and 
30 µL 10% SDS. Bacteria cells were lysed by shaking for 5 min on a minibead beater on high speed 
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and centrifuged at 4500 g for 1 min. DNA was extracted from the supernatant using the QIAamp DNA 
Stool Mini Kit (Qiagen, Doncaster, Victoria, Australia) according to the manufacturer’s instructions 
and stored at −20 °C until use. DNA concentrations were quantified using Quanti-iT Pico Green 
(Invitrogen, Carlsbad, NM, USA) with fluorescence measured using a PTC-200 Peltier Thermal Cycler 
(MJ Research Inc., Waltham, MA, USA). 
Quantitative PCR was performed on DNA extracted from fermentation samples collected on  
Days 8–10 (low amylose cornstarch) and Days 18–20 (XOS and inulin). Primers and amplification 
conditions for quantification of specific bacterial groups and species are listed in Table 1. All reactions 
were performed in 10 µL reactions with 1 µL template DNA (10 ng µL−1), except Akkermansia 
municiphila and sulphate-reducing bacteria (SRB). For these assays 3 μL template DNA (10 ng μL−1) 
was used in a 20 μL reaction. Each reaction contained template DNA, Ssofast Evagreen Supermix (2×) 
(Bio-Rad), primers (Table 1), 0.4 μL BSA (Promega, Sydney, Australia) or 1 μL Dimethyl Sulfoxide 
(SRB only) (Sigma-Aldrich, Sydney, Australia) and Milli-Q to a final volume of 10 or 20 μL. Each 
sample was analysed in triplicates per PCR assay. Amplifications were performed with an initial 
denaturation at 98 °C for 3 min. followed by 35–40 cycles of 98 °C for 15 s, 58–65 °C for 15–60 s and 
72 °C for 30–60 s (Table 1). A final melting-curve analysis was performed after completion of all 
cycles with fluorescence collected at 0.5 °C intervals between 55 and 95 °C. An 8-series of 10-fold 
dilutions of a sample derived plasmid construct (Topo chemical competent cells, Invitrogen, Carlsbad, 
NM, USA) containing the target amplicon were analysed in parallel with DNA samples for estimation 
of PCR efficiency for all assays. All reactions were run on a PTC-200 Peltier Thermal Cycler (MJ 
Research Inc., Waltham, MA, USA) and analysed using MJ Opticon Monitor Analysis Software 
Version 3.1 (Bio-Rad Laboratories, Hercules, CA, USA). For estimation of relative fold change of 
bacterial groups results were analysed with qBase+ (Biogazelle, Gent, Belgium) [19,20]. The data was 
normalised to the total number of bacteria for each sample and expressed as fold change compared to 
the low amylose cornstarch treatment in each vessel for each substrate. All calculations were done 
using an assay specific PCR efficiency. 
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Table 1. Primers and amplification conditions for real-time PCR assays. 
Target Primer Sequence (5′–3′) nM Reference
Annealing Elongation 
°C Time (s) °C Time (s) 
Total bacteria 
1114F 
1275R 
CGGCAACGAGCGCAACCC 
CCATTGTAGCACGTGTGTAGCC 
150 [21] 60 20 72 45 
Bacteroides fragilis group 
Bfr-F 
Bfr-R 
CTGAACCAGCCAAGTAGCG 
CCGCAAACTTTCACAACTGACTTA
500 [22] 58 60 72 30 
Bifidobacterium spp. 
Bif-F 
Bif-R 
TCGCGTC(C/T)GGTGTGAAAG 
CCACATCCAGC(A/G)TCCAC 
600 [23] 58 20 72 30 
Clostridium coccoides group 
g-Ccoc-F 
g-Ccoc-R 
AAATGACGGTACCTGACTAA 
CTTTGAGTTTCATTCTTGCGA A 
250 [24] 58 20 72 45 
Clostridium leptum group 
sg-Clept-F
sg-Clept-R
CTTTGAGTTTCATTCTTGCGAA 
GCACAAGCAGTGGAGT 
250 [24] 58 20 72 45 
Escherichia coli 
E.coli F 
E.coli R 
CATGCCGCGTGTATGAAGAA 
CGGGTAACGTCAATGAGCAAA 
375 [25] 60 20 72 45 
Faecalibacterium praunitzii 
FPR-1F 
FPR-2R 
AGATGGCCTCGCGTCCGA 
CCGAAGACCTTCTTCCTCC 
500 [26] 62 20 72 40 
Lactobacillus group 
Lacto-F 
Lacto-R 
AGCAGTAGGGAATCTTCCA 
CACCGCTACACATGGAG 
500 
[27] 
[28] 
58 30 72 30 
SRB 1_aps 2 
APS3F 
APS2R 
TGGCAGATCATGWTYAAYGG 
GGGCCGTAACCRTCYTTRAA 
400 [29] 58 30 72 60 
SRB_dsr 3 
DSR1F+ 
DSR-R 
ACSCACTGGAAGCACGGCGG 
GTGGMRCCGTGCAKRTTGG 
400 [30] 65 15 72 30 
1 Sulfate-reducing bacteria; 2 Adenosine-5-phosphosulfate reductase gene; 3 Dissimilatory sulfite reductase gene. 
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2.9. Statistics 
SCFA data and DNA damage data was tested for normal distribution using the Shapiro-Wilk test. 
Non-normal distributed data was transformed, propionate concentrations were transformed using 
natural logarithm, whereas tail length was transformed using reflect and square root. Normal and 
transformed data were analysed using a one-way analysis of variance (ANOVA) to assess significant 
difference between groups within fermenter and treatment. PASW version 18 [31] computer software 
was used for these statistical analyses. The microbial data was normalised to the total number of 
bacteria in the sample and presented as fold change relative to the low amylose cornstarch treatment 
for the appropriate vessel and substrate. Microbial fold changes were analysed for changes within 
vessels between inulin and XOS, and between vessels within substrate using the multivariate statistical 
package Primer 6 with Permanova+ (PRIMER-E Ltd., Plymouth, UK) using one- and two-factorial 
analysis based on a Euclidean distance matrix. Distance-based linear models (DISTLM) and distance 
based redundancy analysis (dbRDA) [32,33] was used to investigate the relationship between 
microbial data, DNA damage and biochemical measures To identify the key biochemical measures 
best explaining the relationship between the different data Best was used as selection procedure and 
adjusted R2 as the selection criteria. A P-value of less than 0.05 was considered statistical significant. 
3. Results 
3.1. Faecal Water Genotoxicity 
There were no differences in the effect of inulin fermentation on the genotoxicity of faecal water 
samples from the two vessels when compared to fermentation with cornstarch (Table 2). The 
fermentation of XOS resulted in a significant decrease in faecal water genotoxicity in the PV compared 
to the effect of cornstarch fermentation (Table 2). In contrast, a significant increase in faecal water 
genotoxicity was observed in the DV (Table 2). 
3.2. Short Chain Fatty Acids 
Inulin and XOS significantly increased the concentration of butyrate, but no other major SCFA, in 
the DV relative to the concentrations resulting from fermentation of cornstarch (Table 3). No 
significant effects on SCFA were detected in the PV. 
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Table 2. Faecal water genotoxicity of low amylose cornstarch, inulin and XOS in a human colonic simulator. Genotoxicity (mean ± SEM) 
was measured as numbers of DNA single strand breaks in cultured colonic cells using the comet assay following incubation of the cells with 
faecal water. Data are presented as tail moment and tail length. PV: proximal vessel; DV: distal vessel. 
 
PV (pH 5.5) DV (pH 6.8) PBS 
(control) Pre-inulin Inulin Pre-XOS XOS Pre-inulin Inulin Pre-XOS XOS 
Tail Moment 18.6 ± 1.1 16.0 ± 0.7 7.6 ± 0.4 a 5.4 ± 0.3 b 11.3 ± 0.5 12.1 ± 0.6 6.7 ± 0.3 b 12.8 ± 0.6 a 5.8 ± 0.7 
Tail Length 78.9 ± 3.7 76.7 ± 2.8 44.1 ± 1.7 a 33.3 ± 1.4 b 54.9 ± 1.9 61.2 ± 2.5 34.5 ± 1.2 b 62.0 ± 2.2 a 34.3 ± 3.1 
Means of treatment pairs with unlike superscript letters are significantly different (ANOVA; p < 0.05). 
Table 3. Short chain fatty acid (SCFA) concentrations. SCFA (µmoL/g) are presented as the mean ± SEM and measured in vessels after 
fermentation of low amylose cornstarch (pre-inulin and pre-XOS), inulin and XOS in a human colonic simulator. PV: proximal vessel;  
DV: distal vessel. 
SCFA PV (pH 5.5) DV (pH 6.8) Pre-inulin Inulin Pre-XOS XOS Pre-inulin Inulin Pre-XOS XOS 
Acetate 43 ± 7 47 ± 6 84 ± 4 86 ± 7 95 ± 12 97 ± 9 110 ± 8 104 ± 3 
Propionate 1 ± 0 1 ± 0 3 ± 1 3 ± 1 19 ± 1 22 ± 4 21 ± 2 22 ± 4 
Butyrate 28 ± 4 37 ± 4 15 ± 2 24 ± 6 39 ± 5 a 70 ± 6 b 35 ± 2 a 46 ± 6 b
Total 72 ± 11 85 ± 6 102 ± 6 113 ± 13 153 ± 18 189 ± 14 178 ± 12 181 ± 14
Means of treatment pairs with unlike superscript letters are significantly different (ANOVA; P < 0.05). 
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3.3. Microbial Abundances 
Bacterial populations were analysed for differences between substrates within each vessel and 
between vessels within substrate. In the PV, the Bacteroides fragilis group responded significantly 
differently to XOS and inulin as it increased in response to XOS but decreased in numbers when inulin 
was fermented (Figure 1 and Table 4). Although, inulin stimulated growth in the DV the relative 
abundance of the B. fragilis group was significant higher with XOS (Figure 1 and Table 4). 
Populations of the B. fragilis group also differed significantly between the two vessels for both XOS 
and inulin. Bifidobacterium spp. were increased in both the PV and DV after inulin fermentation and 
decreased in the DV after XOS fermentation (Figure 1 and Table 4). This resulted in a significant 
higher abundance of Bifidobacterium spp. with inulin in both PV and DV, when substrates were 
compared within vessels. In the DV, the relative abundance of the Clostridium coccoides group was 
decreased following inulin fermentation leading to a significant difference between inulin and XOS. 
Both substrates also significantly decreased the relative abundance of the C. coccoides group from PV 
to DV (Figure 1 and Table 4). The Clostridium leptum group was significantly reduced in the DV after 
XOS fermentation this lead to a significant difference between substrates. XOS also resulted in a 
significant difference in these bacteria between the PV and DV (Figure 1 and Table 4). The relative 
fold change of Escherichia coli spp. was significantly higher for XOS than inulin in the PV, this was 
also the case in the DV. Therefore, the relative fold change of E. coli spp. significantly decreased 
between PV and DV during XOS fermentation but not with inulin fermentation. In the PV and DV, 
Faecalibacterium prausnitzii was significantly stimulated by inulin but inhibited by XOS (Figure 1 
and Table 4), but the increase was greater in the PV compared to the DV for inulin which meant a 
significant decrease in F. prausnitzii between the PV and DV for inulin. Lactobacillus spp. was greatly 
stimulated by inulin and only limited by XOS in the PV resulting in a significant difference between 
the two carbohydrates. This significance was carried over into the DV, however, Lactobacillus spp. 
were reduced by XOS. The relative fold change of Lactobacillus spp. was also significantly different 
between vessels for both substrates. SRB measured using the adenosine-5-phosphosulfate reductase 
gene (aps) and the dissimilatory sulfite reductase gene (dsr) both showed a significant reduction in 
SRB relative fold change with inulin and a significant increase with XOS in the PV. In the DV, only 
dsr showed a significant difference between substrates. Both assays also showed a significant 
difference between PV and DV for XOS (Figure 1 and Table 4). 
3.4. Relationships between Microbial Abundance, DNA Damage and SCFA 
The relationships between the abundance of microbes and levels of DNA damage and SCFA were 
investigated. Three variables had a significant relationship with the microbial data (Tail moment:  
p = 0.027; Tail length: p = 0.001; Butyrate: p = 0.011) (Figure 2). Correlation analyses showed that 
acetate was negatively correlated (Pearson’s correlation coefficient (R)) with both tail length  
(R: −0.66; p < 0.001) and tail moment (R: −0.67; p < 0.001). DNA damage was also negatively 
correlated with the relative abundance of B. fragilis (R: −0.49; p = 0.014), SRB_aps (R: −0.41;  
p = 0.044) and SRB_dsr (R: −0.41; p = 0.048). 
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Figure 1. Microbial response to changes in carbohydrate source in a human colonic simulator. Changes are presented as fold change  
(mean ± SEM) relative to low amylose cornstarch treatment for the two vessels and inulin or XOS, respectively. PV: proximal vessel;  
DV: distal vessel. SRB: Sulfate-reducing bacteria, aps: Adenosine-5-phosphosulfate reductase gene, dsr: Dissimilatory sulfite reductase gene. 
 
Table 4. Statistical differences (p < 0.05) between substrates within individual vessels and for substrates between vessels for each bacterial 
group/species. PV: proximal vessel; DV: distal vessel. SRB: Sulfate-reducing bacteria, aps: Adenosine-5-phosphosulfate reductase gene,  
dsr: Dissimilatory sulfite reductase gene. 
Comparisons B. fragilis Bifidobacterium C. coccoides C. leptum E. coli F. prau Lactobacillus SRB_aps SRB_dsr 
PV inulin vs. PV XOS ˃0.0001 0.02 ns ns 0.0007 ˃0.0001 ˃0.0001 0.0002 ˃0.0001 
PV inulin vs. DV inulin 0.003 ns  ˃0.0001 ns ns 0.038 0.007 ns 0.046 
PV XOS vs. DV XOS ˃0.0001 ˃0.0001 0.008 0.0002 0.012 ns ˃0.0001 ˃0.0001 ˃0.0001 
DV XOS vs. DV inulin ˃0.0001 ˃0.0001 ˃0.0001 0.0001 0.030 ˃0.0001 ˃0.0001 ns 0.002 
ns: no significance. 
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Figure 2. Distribution of the variation in the relative microbial abundance displayed based 
on a distance based redundancy analysis (dbRDA) with vectors indicating the weight and 
direction of the best predictor variables from the biochemical results. PV: proximal vessel; 
DV: distal vessel. 
 
4. Discussion 
The present study investigated the effects of adding XOS or inulin to the fermentation of soy 
protein by a mixed faecal microbiota in vessels of a human colonic simulator that approximate the pH 
of the proximal and distal colon. We have demonstrated that XOS, but not inulin, can significantly 
influence the genotoxicity of the fermentation products using this in vitro system and those differences 
may be related to differences in the microbiota. The lowering of the genotoxicity of PV contents by 
XOS fermentation suggests that addition of this oligosaccharide to the diet in humans could protect 
against high dietary protein-induced damage to tissues of the proximal colon. However, in contrast to 
the XOS-induced reduction in genotoxicity in the PV, XOS increased genotoxicity in the DV. In 
humans, tumors occur more frequently in the distal region of the colon than the proximal region and it 
is possible that the pH of the region is an important determinant of the genotoxicity of bacterial 
fermentation products. 
Differences in the genotoxicity between vessels and carbohydrate treatments could be explained by 
changes in the microbiota. The B. fragilis group, E. coli and SRB were stimulated by XOS 
fermentation in the PV whereas for inulin these bacteria were reduced or remained at similar levels. 
Correlation between variables found a significant inverse relationship between the abundances of  
B. fragilis, SRB and the DNA SSB that resulted from incubation of the colonic cells with fecal water, 
suggesting a protective role of these bacteria in this study. Bacteria belonging to the B. fragilis group 
possess the ability to utilise polysaccharides, and a recent study by Petersen et al. [34] demonstrated 
increased levels of the B. fragilis group in the faecal microbiota of mice fed XOS. Our data showing an 
increase in numbers of the B. fragilis group in the PV in response to XOS supports this in vivo data. 
The role of SRB in gastrointestinal health is poorly understood and remains unclear [35] but H2S 
produced by these bacteria can be toxic to the gut epithelium [36]. SRB could contribute to the 
pathogenesis of colorectal diseases, such as inflammatory bowel disease [37], and evidence to date 
indicates that the role of faecal H2S concentrations and colonic Desulfovibrio spp. also remains unclear 
in ulcerative colitis patients [38–41]. However, the abundance of Desulfovibrio spp. reported in some 
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of these studies has to be interpreted with caution, as the PCR primers used overestimate SRB 
abundance [29]. In contrast, gene-specific primers targeting the Adenosine-5-phosphosulfate reductase 
gene and the dissimilatory sulfite reductase gene, and not 16S rRNA primers, were used in this study. 
Our results do not rule out a positive role for SRB in the gut. Other studies support a beneficial role for 
H2S. Wallace et al. [42] have shown that endogenous H2S prevents experimentally-induced colitis in 
rats, suggesting an anti-inflammatory effect. 
The present study did not demonstrate a bifidogenic effect of XOS or inulin as seen in previous 
studies [12,34,43,44]. However, changes in Lactobacillus spp. occurred as expected, with inulin 
increasing the Lactobacillus spp. and XOS not having a real effect [34,45,46]. 
There is a growing body of evidence that the SCFA, particularly butyrate, are key mediators of the 
bowel health benefits of dietary fibre [3,47–49], although products of bacterial fermentation other than 
SCFA could also contribute to the health of the bowel. In the present study, a significant elevation in 
the concentration of butyrate, but no other SCFA, was seen in the DV for both XOS and inulin when 
compared with low amylose cornstarch but this did not translate to a lower genotoxicity of the content 
of these vessels. This suggested another factor was the primary contributor to differences in 
genotoxicity. Further analysis of the relationships between variables showed there was a strong inverse 
correlation between acetate and the faecal water genotoxicity. A similar observation has been made 
previously by Toden et al. [3] in a study examining the effects of RS on colonic DNA damage in rats. 
Acetate has also been shown to help protect against enteropathogenic infections [14] and a similar 
protection of the HT-29 cells may occur in our faecal water genotoxicity assay. As acetate is the most 
abundant of the SCFA produced in the gut its actions are often thought to be related to its capacity to 
lower pH, but that cannot be the case in this study as pH was kept constant in the two vessels. This and 
other studies [3,14] indicate that acetate may have a direct effect on protection against DNA damage, 
whereas butyrate has a secondary effect through its ability to repair DNA damage. However, the 
relationship between acetate and DNA damage needs further investigation. 
The increase in butyrate concentrations in response to XOS and inulin would be expected to be 
related to changes in bacterial populations and/or their metabolic activity, including increased numbers 
of butyrate-producers. In humans, some of the most numerically abundant butyrate-producers are 
Roseburia spp. and Eubacterium rectale, both members of the C. coccoides group, and F. prausnitzii, 
which belongs to the C. leptum group [49]. The current study indicates that the increases in DV butyrate 
levels for inulin and XOS were likely to come from different groups of bacteria. Inulin increased 
bacteria of the C. leptum group and F. prausnitzii, as seen in the study of Ramirez-Farias et al. [12], 
but decreased the C. coccoides group in the DV. This was the opposite with XOS fermentation which 
increased numbers of the C. coccoides group and lowered numbers of F. prausnitzii and the C. leptum 
group. This difference could be due to differences in length and structure of the two carbohydrates. 
5. Conclusions 
The addition of XOS to a simulator of human colonic fermentation has demonstrated that it  
can alter the genotoxicity of fermented material in the presence of soy protein. The decrease in 
genotoxicity within the PV suggests dietary XOS could potentially lower protein-induced proximal 
colon genotoxicity and tissue damage in humans. The effects of XOS but not inulin on genotoxicity 
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may be related to observed differences in effects of these substrates on the microbiota. Different 
populations of bacteria seem to be responsible for increased production of butyrate by inulin and XOS. 
This study also indicates a role for acetate in relation to protection against DNA damage, but that 
relationship requires further investigation. 
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